1. Chemical Characterization, Antioxidant and anti-HIV Activities of a Brazilian Propolis from Ceara State. da Silva, C.C.F., A. Salatino, L.B. da Motta, G. Negri, and M.L.F. Salatino. Revista Brasileira de Farmacognosia, 2019. 29(3): p. 309-318. ISI[000476478900006].
[WOS]. HIV_08_2019.
2. Molecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as anti-HIV-1 Agents. Faghihi, K., M. Safakish, T. Zebardast, Z. Hajimandi, and A. Zarghi. Iranian Journal of Pharmaceutical Research, 2019. 18(3): p. 1253-1263. ISI[000476917500010].
[WOS]. HIV_08_2019.
3. Biological Activity and Stability Analyses of Knipholone anthrone, a Phenyl anthraquinone Derivative Isolated from Kniphofia foliosa Hochst. Feilcke, R., G. Arnouk, B. Raphane, K. Richard, I. Tietjen, K. Andrae-Marobela, F. Erdmann, S. Schipper, K. Becker, N. Arnold, A. Frolov, N. Reiling, P. Imming, and S.A.T. Fobofou. Journal of Pharmaceutical and Biomedical Analysis, 2019. 174: p. 277-285. PMID[31185339].
[PubMed]. HIV_08_2019.
4. Potent HIV-1 Protease Inhibitors Incorporating Squaramide-derived P2 Ligands: Design, Synthesis, and Biological Evaluation. Ghosh, A.K., J.N. Williams, S. Kovela, J. Takayama, H.M. Simpson, D.E. Walters, S.I. Hattori, M. Aoki, and H. Mitsuya. Bioorganic & Medicinal Chemistry Letters, 2019. 29(18): p. 2565-2570. PMID[31416666]. PMCID[PMC6711809].
[PubMed]. HIV_08_2019.
5. Exploratory Synthesis of Novel Cyclic and Straight-chain 1,3-Azaborines as Potential HIV-1 Protease Inhibitors. Hawley, K., R. Latsis, C. Suarez, K. Norris, A. Vulcano, S. Dawson, A. Williams, A. Lanin, J. Murray, and L. Fabry-Asztalos. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478861202804].
[WOS]. HIV_08_2019.
6. Dimeric Pyranonaphthoquinone glycosides with anti-HIV and Cytotoxic Activities from a Soil-derived Streptomyces. He, X., Y.J. Wang, R.H. Luo, L.M. Yang, L. Wang, D.L. Guo, J. Yang, Y. Deng, Y.T. Zheng, and S.X. Huang. Journal of Natural Products, 2019. 82(7): p. 1813-1819. PMID[31310115].
[PubMed]. HIV_08_2019.
7. Curaxin CBL0137 Has the Potential to Reverse HIV-1 Latency. Jean, M.J., D. Zhou, G. Fiches, W. Kong, H. Huang, A. Purmal, K. Gurova, N.G. Santoso, and J. Zhu. Journal of Medical Virology, 2019. 91(8): p. 1571-1576. PMID[30989696]. PMCID[PMC6599568].
[PubMed]. HIV_08_2019.
8. A Novel anti-HIV-1 Bispecific bNAb-lectin Fusion Protein Engineered in a Plant-based Transient Expression System. Kasinger, L.E.S., M.W. Dent, G. Mahajan, K.T. Hamorsky, and N. Matoba. Plant Biotechnology Journal, 2019. 17(8): p. 1646-1656. PMID[30729651]. PMCID[PMC6662308].
[PubMed]. HIV_08_2019.
9. Synthesis and Structure-Activity Relationship Correlations of Gnidimacrin Derivatives as Potent HIV-1 Inhibitors and HIV Latency Reversing Agents. Liu, Q., Y.Y. Cheng, W. Li, L. Huang, Y. Asada, M.T. Hsieh, S.L. Morris-Natschke, C.H. Chen, K. Koike, and K.H. Lee. Journal of Medicinal Chemistry, 2019. 62(15): p. 6958-6971. PMID[31343875].
[PubMed]. HIV_08_2019.
10. Synthesis of Nucleoside Analogs for Inhibition of HIV-1 RT. Mueller-Mabry, B., C. Ledezma, and D. Kolpashchikov. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478860501211].
[WOS]. HIV_08_2019.
11. Biological Evaluation of Molecules of the azaBINOL Class as Antiviral Agents: Inhibition of HIV-1 RNase H Activity by 7-Isopropoxy-8-(naphth-1-yl)quinoline. Overacker, R.D., S. Banerjee, G.F. Neuhaus, S. Milicevic Sephton, A. Herrmann, J.A. Strother, R. Brack-Werner, P.R. Blakemore, and S. Loesgen. Bioorganic & Medicinal Chemistry, 2019. 27(16): p. 3595-3604. PMID[31285097].
[PubMed]. HIV_08_2019.
12. N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting gp41 of HIV-1 Envelope Glycoprotein. Qiu, J., T. Liang, J. Wu, F. Yu, X. He, Y. Tian, L. Xie, S. Jiang, S. Liu, and L. Li. Frontiers in Pharmacology, 2019. 10: p. 859. PMID[31427969]. PMCID[PMC6688628].
[PubMed]. HIV_08_2019.
13. Follow on-based Optimization of the Biphenyl-DAPYs as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors against the Wild-type and Mutant Strains. Sang, Y.L., S. Han, S.W. Han, C. Pannecouque, E. De Clercq, C.L. Zhuang, and F.E. Chen. Bioorganic Chemistry, 2019. 89: 102974. PMID[31102693].
[PubMed]. HIV_08_2019.
14. In Vitro anti-HIV-1 Activity of the Bioactive Compound Extracted and Purified from Two Different Marine Macroalgae (Seaweeds) (Dictyota bartayesiana J.V.Lamouroux and Turbinaria decurrens Bory). Sanniyasi, E., G. Venkatasubramanian, M.M. Anbalagan, P.P. Raj, and R.K. Gopal. Scientific Reports, 2019. 9(12185): 12pp. PMID[31434919]. PMCID[PMC6704075].
[PubMed]. HIV_08_2019.
15. Molecular and Cellular Studies Evaluating a Potent 2-Cyanoindolizine Catechol Diether NNRTI Targeting Wildtype and Y181C Mutant HIV-1 Reverse Transcriptase. Sasaki, T., Z.T.K. Gannam, S.N. Kudalkar, K.M. Frey, W.G. Lee, K.A. Spasov, W.L. Jorgensen, and K.S. Anderson. Bioorganic & Medicinal Chemistry Letters, 2019. 29(16): p. 2182-2188. PMID[31281023]. PMCID[PMC6690785].
[PubMed]. HIV_08_2019.
16. Designing and Synthesis of Novel Scaffold by Adopting Ligand and Structure-based Approaches as HIV-1 Entry Inhibitor Specially Targeting to Viral Glycoprotein gp120. Shah, K., J. Chavda, and H. Bhatt. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478861202664].
[WOS]. HIV_08_2019.
17. Identification of Novel 3-Hydroxy-pyran-4-one Derivatives as Potent HIV-1 Integrase Inhibitors Using in Silico Structure-based Combinatorial Library Design Approach. Sirous, H., G. Chemi, S. Gemma, S. Butini, Z. Debyser, F. Christ, L. Saghaie, S. Brogi, A. Fassihi, G. Campiani, and M. Brindisi. Frontiers in Chemistry, 2019. 7: p. 574. PMID[31457006]. PMCID[PMC6700280].
[PubMed]. HIV_08_2019.
18. 3D-QSAR Studies of S-DABO Derivatives as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Wang, Y.P., J. Chang, J.Y. Wang, P. Zhong, Y.F. Zhang, C.C. Lai, and Y.P. Hez. Letters in Drug Design & Discovery, 2019. 16(8): p. 868-881. ISI[000480359800005].
[WOS]. HIV_08_2019.
19. Small Molecule ONC201 Inhibits HIV-1 Replication in Macrophages via FOXO3a and Trail. Zhao, R., Y. Li, S. Gorantla, L.Y. Poluektova, H. Lin, F. Gao, H. Wang, J. Zhao, J.C. Zheng, and Y. Huang. Antiviral Research, 2019. 168: p. 134-145. PMID[31158413].
[PubMed]. HIV_08_2019.
Patent Citations
20. Preparation of Benzamide Compounds as Antitumor and anti-HIV Agents. Pinchman, J.R., P.Q. Huang, K.D. Bunker, R.K. Sit, and A.A. Samatar. Patent. 2019. 2019-US12719 2019139907: 236pp.
[Patent]. HIV_08_2019.
21. Preparation of Benzamide Compounds as Antitumor and anti-HIV Agents. Pinchman, J.R., P.Q. Huang, K.D. Bunker, R.K. Sit, and A.A. Samatar. Patent. 2019. 2019-US12695 2019139899: 235pp.
[Patent]. HIV_08_2019.